Literature DB >> 31800053

A Forced-Choice Procedure to Assess the Acute Relative Reinforcing Effects of Nicotine Dose per se in Humans.

Kenneth A Perkins1, Joshua L Karelitz1.   

Abstract

INTRODUCTION: A method to assess acute reinforcement due to nicotine may aid identification of doses needed to maintain dependence. After describing development of a forced-choice procedure, results are presented from two studies using it to determine the relative reinforcing effects of nicotine dose per se. AIMS AND METHODS: Choice between a higher versus a very low or no nicotine option, via smoking (Study 1, n = 59) and via nasal spray (Study 2, n = 42), was assessed in nontreatment-seeking dependent smokers abstinent overnight. Using a within-subject design, different nicotine levels for each product were administered under blind conditions, initially to assess their discriminability (Study 1: 1.3-17 mg/g each vs. 0.4 mg/g nicotine Spectrum cigarettes; Study 2: 2.5 µg/kg vs. 0 µg/kg nicotine per spray). At the end of sessions for each study, participants engaged in forced-choice trials to assess preference, requiring a fixed number of puffs/sprays for one and/or the other.
RESULTS: Confirming the procedure's validity, the choice of the higher nicotine option was significantly greater than that for the very low or no nicotine option in both studies. In Study 1, choice relative to 0.4 mg/g was greater for cigarettes 5.3 mg/g or more but not 2.3 mg/g or less (p = .003 for the interaction of higher content vs. 0.4 mg/g comparison). In Study 2, choice was greater for the nicotine versus placebo spray (p < .005), as nicotine was preferred nearly twice as much as the placebo.
CONCLUSION: This forced-choice procedure may efficiently determine the relative reinforcing value of a nicotine dose per se. IMPLICATIONS: The forced-choice procedure described here may identify nicotine doses that are acutely reinforcing in dependent smokers. A priori research of choice comparisons between small versus zero nicotine doses could inform clinical research in larger and more diverse samples to determine nicotine contents in cigarettes, and perhaps in other commercial products, that are not reinforcing and, thus, likely to reduce the risk of their addictiveness. This procedure may also be applicable to assessing changes in acute nicotine reinforcement due to different product formulations, novel drugs, or other manipulations, perhaps helping inform development of new interventions for cessation or harm reduction.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31800053      PMCID: PMC7542652          DOI: 10.1093/ntr/ntz224

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  44 in total

Review 1.  Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents.

Authors:  L T Kozlowski; R J O'Connor
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

2.  Reduced nicotine reward in obesity: cross-comparison in human and mouse.

Authors:  Julie A Blendy; Andrew Strasser; Carrie L Walters; Kenneth A Perkins; Freda Patterson; Robert Berkowitz; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

3.  Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms.

Authors:  R D Hurt; K P Offord; I T Croghan; G A Croghan; L C Gomez-Dahl; T D Wolter; L C Dale; T P Moyer
Journal:  Psychopharmacology (Berl)       Date:  1998-11       Impact factor: 4.530

4.  The Future of Nicotine Regulation: Key Questions and Challenges.

Authors:  Mitch Zeller
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

5.  Naturalistic assessment of demand for cigarettes, snus, and nicotine gum.

Authors:  Jeffrey S Stein; A George Wilson; Mikhail N Koffarnus; Michael C Judd; Warren K Bickel
Journal:  Psychopharmacology (Berl)       Date:  2016-10-11       Impact factor: 4.530

6.  Nicotine self-administration: cigarette versus nicotine gum diurnal topography.

Authors:  Marc Mooney; Charles Green; Dorothy Hatsukami
Journal:  Hum Psychopharmacol       Date:  2006-12       Impact factor: 1.672

7.  Intravenous Nicotine Self-Administration in Smokers: Dose-Response Function and Sex Differences.

Authors:  Kevin P Jensen; Elise E DeVito; Gerald Valentine; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  Neuropsychopharmacology       Date:  2015-12-31       Impact factor: 7.853

8.  Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.

Authors:  R Ray; C Jepson; F Patterson; A Strasser; M Rukstalis; K Perkins; K G Lynch; S O'Malley; W H Berrettini; C Lerman
Journal:  Psychopharmacology (Berl)       Date:  2006-09-08       Impact factor: 4.530

9.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

10.  Forced-choice versus free-choice procedures: caffeine self-administration in humans.

Authors:  A H Oliveto; J R Hughes; S T Higgins; W K Bickel; S L Pepper; P J Shea; J W Fenwick
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  3 in total

Review 1.  Acute nicotine reinforcement requires ability to discriminate the stimulus effects of nicotine.

Authors:  Kenneth A Perkins
Journal:  Exp Clin Psychopharmacol       Date:  2020-10-29       Impact factor: 3.492

2.  Acute subjective sensory perceptions predict relative reinforcing effects of smoked nicotine.

Authors:  Joshua L Karelitz; Kenneth A Perkins
Journal:  Addict Behav       Date:  2021-01-15       Impact factor: 4.591

3.  Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.

Authors:  Dorothy K Hatsukami; Dongqun Xu; Geoffrey Ferris Wayne
Journal:  Nicotine Tob Res       Date:  2022-03-01       Impact factor: 5.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.